Business Description
Ishita Drugs And Industries Ltd
ISIN : INE806D01016
Share Class Description:
BOM:524400: Shs DematerialisedTotal Employee Number:
14Compare
Compare
Traded in other countries / regions
524400.India IPO Date
1994-02-15Description
Ishita Drugs And Industries Ltd is engaged in the business of manufacturing various APIs and drug intermediates. The company supplies its products to various pharmaceutical companies and is also being exported to various countries across the world. The company has three manufacturing facilities located in the state of Gujarat, two for APIs and drug intermediates at Ahmedabad and Surendranagar, and one for finished pharmaceutical formulations at Mehsana.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 83.5 | |||||
Equity-to-Asset | 0.92 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.07 | |||||
Interest Coverage | 11.25 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 15.16 | |||||
Beneish M-Score | -3.04 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.6 | |||||
3-Year EBITDA Growth Rate | 9.4 | |||||
3-Year EPS without NRI Growth Rate | 10.4 | |||||
3-Year Book Growth Rate | 8 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 34.3 | |||||
9-Day RSI | 45.78 | |||||
14-Day RSI | 48.52 | |||||
3-1 Month Momentum % | -9.77 | |||||
6-1 Month Momentum % | 0.15 | |||||
12-1 Month Momentum % | -1.22 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 9.65 | |||||
Quick Ratio | 8.72 | |||||
Cash Ratio | 6.91 | |||||
Days Inventory | 82.99 | |||||
Days Sales Outstanding | 29.19 | |||||
Days Payable | 24.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | 8.85 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 29.66 | |||||
Operating Margin % | 4.54 | |||||
Net Margin % | 5.31 | |||||
EBITDA Margin % | 8.45 | |||||
FCF Margin % | 14.11 | |||||
OCF Margin % | 26.73 | |||||
ROE % | 6.95 | |||||
ROA % | 5.37 | |||||
ROIC % | 9.12 | |||||
3-Year ROIIC % | 0.92 | |||||
ROC (Joel Greenblatt) % | 30.76 | |||||
ROCE % | 10.11 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 28.6 | |||||
PE Ratio without NRI | 28.6 | |||||
Shiller PE Ratio | 31.3 | |||||
Price-to-Owner-Earnings | 6.26 | |||||
PEG Ratio | 15.05 | |||||
PS Ratio | 1.52 | |||||
PB Ratio | 1.92 | |||||
Price-to-Tangible-Book | 1.92 | |||||
Price-to-Free-Cash-Flow | 10.76 | |||||
Price-to-Operating-Cash-Flow | 5.68 | |||||
EV-to-EBIT | 13.6 | |||||
EV-to-EBITDA | 12.5 | |||||
EV-to-Revenue | 1.06 | |||||
EV-to-FCF | 7.49 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 2.18 | |||||
Price-to-Median-PS-Value | 1.61 | |||||
Price-to-Graham-Number | 1.56 | |||||
| Price-to-Net-Current-Asset-Value | 2.61 | |||||
| Price-to-Net-Cash | 3.84 | |||||
Earnings Yield (Greenblatt) % | 7.35 | |||||
FCF Yield % | 9.3 | |||||
Forward Rate of Return (Yacktman) % | 1.68 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ishita Drugs And Industries Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 146.602 | ||
| EPS (TTM) (₹) | 2.6 | ||
| Beta | 1.196 | ||
| 3-Year Sharpe Ratio | -0.01 | ||
| 3-Year Sortino Ratio | -0.02 | ||
| Volatility % | 33.15 | ||
| 14-Day RSI | 48.52 | ||
| 14-Day ATR (₹) | 2.470082 | ||
| 20-Day SMA (₹) | 74.181 | ||
| 12-1 Month Momentum % | -1.22 | ||
| 52-Week Range (₹) | 66 - 90.85 | ||
| Shares Outstanding (Mil) | 2.99 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ishita Drugs And Industries Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ishita Drugs And Industries Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ishita Drugs And Industries Ltd Frequently Asked Questions
What is Ishita Drugs And Industries Ltd(BOM:524400)'s stock price today?
The current price of BOM:524400 is ₹74.37. The 52 week high of BOM:524400 is ₹90.85 and 52 week low is ₹66.00.
When is next earnings date of Ishita Drugs And Industries Ltd(BOM:524400)?
The next earnings date of Ishita Drugs And Industries Ltd(BOM:524400) is .
Does Ishita Drugs And Industries Ltd(BOM:524400) pay dividends? If so, how much?
Ishita Drugs And Industries Ltd(BOM:524400) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Ishita Drugs And Industries Ltd
No articles.